Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0783 per EA under NDC 62332005030. Its NADAC has been published 511 times since Nov 9, 2016.

FDA first approved this application on Feb 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB

Losartan Potassium and Hydrochlorothiazide
$0.0783per EA

Strength

25; 100 mg/1; mg/1

NDC

62332005030

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091617

FDA Approved

2/17/2012

TE Code

AB

On Market Since

5/23/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 511 times since Nov 9, 2016, and over the history we have for it it has declined 22.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0783 per EA
All-time high$0.2811 (May 11, 2022)
All-time low$0.0771 (Jan 23, 2019)
52-week high$0.0876
52-week low$0.0771
Median price$0.1078
Average price$0.1238
Largest weekly change+41.4% (Jan 29, 2020)
Weeks tracked511
Tracking sinceNov 9, 2016

Price History

1W

+1.6%

1M

+1.6%

3M

-3.4%

6M

-3.5%

1Y

-7.6%

3Y

-37.2%

5Y

-54.5%

All

-22.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $0.0783 per EA (NDC 62332005030), effective Aug 19, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 22.3%. It has been tracked across 511 weekly CMS publications since Nov 9, 2016.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

Since Nov 9, 2016, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0771 (Jan 23, 2019) to a high of $0.2811 (May 11, 2022), with a median of $0.1078 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 62332005030) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.